485 related articles for article (PubMed ID: 22307533)
1. ¹⁸F-Fluoromisonidazole positron emission tomography may differentiate glioblastoma multiforme from less malignant gliomas.
Hirata K; Terasaka S; Shiga T; Hattori N; Magota K; Kobayashi H; Yamaguchi S; Houkin K; Tanaka S; Kuge Y; Tamaki N
Eur J Nucl Med Mol Imaging; 2012 May; 39(5):760-70. PubMed ID: 22307533
[TBL] [Abstract][Full Text] [Related]
2. Correlation between ¹⁸F-fluoromisonidazole PET and expression of HIF-1α and VEGF in newly diagnosed and recurrent malignant gliomas.
Kawai N; Lin W; Cao WD; Ogawa D; Miyake K; Haba R; Maeda Y; Yamamoto Y; Nishiyama Y; Tamiya T
Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1870-8. PubMed ID: 24781871
[TBL] [Abstract][Full Text] [Related]
3. [18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular markers of hypoxia and angiogenesis.
Bekaert L; Valable S; Lechapt-Zalcman E; Ponte K; Collet S; Constans JM; Levallet G; Bordji K; Petit E; Branger P; Emery E; Manrique A; Barré L; Bernaudin M; Guillamo JS
Eur J Nucl Med Mol Imaging; 2017 Aug; 44(8):1383-1392. PubMed ID: 28315948
[TBL] [Abstract][Full Text] [Related]
4. Correlation of biological aggressiveness assessed by 11C-methionine PET and hypoxic burden assessed by 18F-fluoromisonidazole PET in newly diagnosed glioblastoma.
Kawai N; Maeda Y; Kudomi N; Miyake K; Okada M; Yamamoto Y; Nishiyama Y; Tamiya T
Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):441-50. PubMed ID: 21072512
[TBL] [Abstract][Full Text] [Related]
5. Hypoxic glucose metabolism in glioblastoma as a potential prognostic factor.
Toyonaga T; Yamaguchi S; Hirata K; Kobayashi K; Manabe O; Watanabe S; Terasaka S; Kobayashi H; Hattori N; Shiga T; Kuge Y; Tanaka S; Ito YM; Tamaki N
Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):611-619. PubMed ID: 27752745
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia assessed by 18F-fluoromisonidazole positron emission tomography in newly diagnosed gliomas.
Yamamoto Y; Maeda Y; Kawai N; Kudomi N; Aga F; Ono Y; Nishiyama Y
Nucl Med Commun; 2012 Jun; 33(6):621-5. PubMed ID: 22422099
[TBL] [Abstract][Full Text] [Related]
7. Integrated analysis of dynamic FET PET/CT parameters, histology, and methylation profiling of 44 gliomas.
Röhrich M; Huang K; Schrimpf D; Albert NL; Hielscher T; von Deimling A; Schüller U; Dimitrakopoulou-Strauss A; Haberkorn U
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(9):1573-1584. PubMed ID: 29732524
[TBL] [Abstract][Full Text] [Related]
8. Applying a patient-specific bio-mathematical model of glioma growth to develop virtual [18F]-FMISO-PET images.
Gu S; Chakraborty G; Champley K; Alessio AM; Claridge J; Rockne R; Muzi M; Krohn KA; Spence AM; Alvord EC; Anderson AR; Kinahan PE; Swanson KR
Math Med Biol; 2012 Mar; 29(1):31-48. PubMed ID: 21562060
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of FMISO-PET for glioma analysis.
Kobayashi H; Hirata K; Yamaguchi S; Terasaka S; Shiga T; Houkin K
Neurol Med Chir (Tokyo); 2013; 53(11):773-8. PubMed ID: 24172591
[TBL] [Abstract][Full Text] [Related]
10. Quantitative metrics of net proliferation and invasion link biological aggressiveness assessed by MRI with hypoxia assessed by FMISO-PET in newly diagnosed glioblastomas.
Szeto MD; Chakraborty G; Hadley J; Rockne R; Muzi M; Alvord EC; Krohn KA; Spence AM; Swanson KR
Cancer Res; 2009 May; 69(10):4502-9. PubMed ID: 19366800
[TBL] [Abstract][Full Text] [Related]
11. Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies.
Cher LM; Murone C; Lawrentschuk N; Ramdave S; Papenfuss A; Hannah A; O'Keefe GJ; Sachinidis JI; Berlangieri SU; Fabinyi G; Scott AM
J Nucl Med; 2006 Mar; 47(3):410-8. PubMed ID: 16513609
[TBL] [Abstract][Full Text] [Related]
12. (18)F-fluoromisonidazole positron emission tomography can predict pathological necrosis of brain tumors.
Toyonaga T; Hirata K; Yamaguchi S; Hatanaka KC; Yuzawa S; Manabe O; Kobayashi K; Watanabe S; Shiga T; Terasaka S; Kobayashi H; Kuge Y; Tamaki N
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1469-76. PubMed ID: 26841941
[TBL] [Abstract][Full Text] [Related]
13. FMISO-PET-derived brain oxygen tension maps: application to glioblastoma and less aggressive gliomas.
Chakhoyan A; Guillamo JS; Collet S; Kauffmann F; Delcroix N; Lechapt-Zalcman E; Constans JM; Petit E; MacKenzie ET; Barré L; Bernaudin M; Touzani O; Valable S
Sci Rep; 2017 Aug; 7(1):10210. PubMed ID: 28860608
[TBL] [Abstract][Full Text] [Related]
14. Prediction of pathology and survival by FDG PET in gliomas.
Padma MV; Said S; Jacobs M; Hwang DR; Dunigan K; Satter M; Christian B; Ruppert J; Bernstein T; Kraus G; Mantil JC
J Neurooncol; 2003 Sep; 64(3):227-37. PubMed ID: 14558598
[TBL] [Abstract][Full Text] [Related]
15. Change in 18F-Fluoromisonidazole PET Is an Early Predictor of the Prognosis in the Patients with Recurrent High-Grade Glioma Receiving Bevacizumab Treatment.
Yamaguchi S; Hirata K; Toyonaga T; Kobayashi K; Ishi Y; Motegi H; Kobayashi H; Shiga T; Tamaki N; Terasaka S; Houkin K
PLoS One; 2016; 11(12):e0167917. PubMed ID: 27936194
[TBL] [Abstract][Full Text] [Related]
16. ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron emission tomography/CT in the evaluation of patients with suspected primary and residual/recurrent gliomas.
Li DL; Xu YK; Wang QS; Wu HB; Li HS
Chin Med J (Engl); 2012 Jan; 125(1):91-6. PubMed ID: 22340472
[TBL] [Abstract][Full Text] [Related]
17. In Vivo Relationship Between Hypoxia and Angiogenesis in Human Glioblastoma: A Multimodal Imaging Study.
Ponte KF; Berro DH; Collet S; Constans JM; Emery E; Valable S; Guillamo JS
J Nucl Med; 2017 Oct; 58(10):1574-1579. PubMed ID: 28596159
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.
Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F
World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307
[TBL] [Abstract][Full Text] [Related]
19. Comparison of (18)F-FET and (18)F-FDG PET in brain tumors.
Pauleit D; Stoffels G; Bachofner A; Floeth FW; Sabel M; Herzog H; Tellmann L; Jansen P; Reifenberger G; Hamacher K; Coenen HH; Langen KJ
Nucl Med Biol; 2009 Oct; 36(7):779-87. PubMed ID: 19720290
[TBL] [Abstract][Full Text] [Related]
20. Analysis of hypoxia in human glioblastoma tumors with dynamic 18F-FMISO PET imaging.
Abdo RA; Lamare F; Fernandez P; Bentourkia M
Australas Phys Eng Sci Med; 2019 Dec; 42(4):981-993. PubMed ID: 31520369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
